Republic Republic Republic
  • Log in
Open account
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Live deals Investment opportunities Trading Buy and sell Republic Note Own a piece of Republic's upside
Republic Ventures Opportunities for accredited investors
Republic Capital Multi-stage venture firm
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US

  • Log in
  • Open account
All investors
Live deals Investment opportunities Trading Buy and sell
Republic Note Own a piece of Republic's upside
Accredited only
Republic Ventures Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward Founder Academy A complete guide to raising funds
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets
Tokenization Deploy your assets on-chain
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services
Logo of CNS Pharma
CNS Pharma Updates
Entry must be under 140 characters.
Cancel
Nov 8
2019

Congratulations CNSP shareholders - Now to the logistics

First of all, congratulations to all my fellow CNSP shareholders! It was a long road but we would not be here without all of you.  

We are getting some questions about how your SAFE investment will convert into common shares with our IPO and want to provide some information here:  

While CNSP began TRADING today, the IPO itself is currently scheduled to CLOSE on Wednesday, November 13, 2019.  To repeat, our common shares, under the symbol CNSP, did start trading on Nasdaq today but our IPO has not yet closed.

Now, before there are even more questions, your SAFE investment instruments define “IPO” as: the closing of the Company’s first initial public offering of Common Stock pursuant to either an effective registration statement filed under the Securities Act or a qualified offering statement filed pursuant to Regulation A of the Securities Act."  So, upon the close of the IPO your SAFE investment will convert into common shares at the discounted rate of $3.36 ($4.00 x 16% discount).  

Welcome letters will be mailed out upon the issuance of your shares by the transfer agent with information on how to access your account with Continental Stock.  If you would like information before the letters are received that is not a problem, you can contact the transfer agent directly at cstmail@continentalstock.com or 800-509-5586 (Monday - Friday, 8:30am - 5:30pm EST).

All the best,

John

Profile picture of John Climaco
John Climaco
CNS Pharma
Liked
Like
11
Comments (15)
The comment you're trying to see no longer exists.
Profile picture of Prasanna Airody
Prasanna Airody
6 years ago
@John-climaco I still have not heard from Continental Stock. I sent an email to cstmail@continentalstock.com and no response so far. When should I expect the welcome letter? I have not received any email so far. Thank you.
0 Like Reply
Profile picture of Jeff Park
Jeff Park
almost 7 years ago
@john-climaco I still have not heard from Continental Stock. When should we expect the welcome letter? Will it be sent via email?
1 like Reply
Profile picture of Kevin Law
Kevin Law @jeff-park You will receive physical letters from Continental Stock
Almost 7 years ago
0 Like
·
Reply
·
Almost 7 years ago
Profile picture of Gregg Carlson
Gregg Carlson @jeff-park I Just put in a call into Continental Stock Transfer and the transfer over to my brokerage account was easy. In this case, my brokerage account is Etrade so I was able to fill out the online form in 10 minutes. I would call your brokerage account to help you find the correct form. You will probably need a copy of your Continental statement which might be required to upload and finalize the process. You may also keep your stocks at Continental if you wish. I hope this helps!
6 years ago
0 Like
·
Reply
·
6 years ago
Profile picture of Aaron Hartley
Aaron Hartley
almost 7 years ago
ALL,
I spoke with Continental this morning, here is what I have gleaned, hope this helps you!!
You should (will) be receiving a document from continental. Then you should do as instructed and create an account. You will most likely need to submit a W-9 form to them either physically or via email, with your taxpayer I.D. (SS number EIN etc) as it seems most of our Taxpayer I.D. numbers were NOT filed upon IPO (a clerical error by someone). Then once the document has been recorded and is filed with Continental, THEN you can simply call or email your brokerage firm (ETrade, TD Ameritrade, Schwab etc...) and submit the form "Direct Registration Transaction Advice" from Continental requesting YOUR shares to be transferred to your brokerage account. After that you are free to do as you wish with them. I am pretty sure we have no lockup period...

Alternatively you may request physical share certificate to keep in your safe deposit box, or just keep your shares on Continental for the time being.

Note that CNSP is actively trading and... IMO, NOT ADVICE... as I'm not a fiduciary... is growing!! Todays news of worldwide rights acquired and impending application to FDA for approval of Berubicin with Orphan Drug status is a huge catalyst!

Now all we have left to do is everything! Good luck and I hope my research has helped you navigate this process.

Wonderful news John Climaco! Go beat this disease down like the scourge of the Earth it is!!!
1 like Reply
Profile picture of Jeff Park
Jeff Park @aaron-hartley Thanks for sharing! I assume Continental will contact us via email?
Almost 7 years ago
0 Like
·
Reply
·
Almost 7 years ago
Profile picture of Aaron Hartley
Aaron Hartley @jeff-park Snail mail. Physical documents. I just got mine yesterday.
Almost 7 years ago
0 Like
·
Reply
·
Almost 7 years ago
Profile picture of Hang kuen  Leung
Hang kuen Leung
almost 7 years ago
@john-climaco , just called the contientalstock.com, received very ruled customser services, maybe I wasn't familiar about stock crowdfunding platform, the lady who answered my call were stating that they are only the record company, they have no way to tell you whether you owned the shares of stock or not, they claimed that we have to have a brokerage account with other company, so let say if I want to hold it or sale it and buy more ..what should I do, also, can someone explained to me that if our investment that invested in cns pharma were suceeded, so we are getting some kind of money instead of having option to get to keep the stocks until we decided when to sake it, please explained

contientalstock.com

0 Like Reply
Profile picture of Raymond Sorber
Raymond Sorber
almost 7 years ago
Now that you are the Engineer, steering this train, you will find many people tugging you in different directions. You are the engineer. That said, surround yourself with good accountants and honest lawyers, then get a good financial planner. Looking into the future , sure is fun. Once
your initial goal is achieved , then there MUST be a 2nd and a 3rd, to keep OUR company relevant and profitable, at the same time.
Happy Holiday to you and your staff. Beancounter Ray
0 Like Reply
Profile picture of michael  baylor
michael baylor
almost 7 years ago
I am very happy to hear that cns pharma has taken the next step towards fighting this terrible disease. I am an investor and a person who has been horribly affected by this disease. my heart was filled with joy when I read this company's presentation. Win or lose I love this effort.
3 likes Reply
Profile picture of Hang kuen  Leung
Hang kuen Leung
almost 7 years ago
Congratulations for cns pharma, I knew u guys would heck in the NASDAQ, I trusted my instinct, here u go to the next level, I just have some questions, I was one of the person who did invest, so does our investment now turn on ipo and that we are able to use discount rate to purchase more and also our previous investment was worth some of the share, please let me know whom I can contact for further explanation, thanks, Heidi
0 Like Reply
Profile picture of John Brooks
John Brooks
almost 7 years ago
John,
Will the shares be restricted. Is there a lockup period on the shares ?
1 like Reply
Profile picture of William  Skyles
William Skyles
almost 7 years ago
John. first and foremost congratulation on IPO and thank you for all your hard work and communication. This crowdfunding is new to all but I do wish Repblic and CST would have communicated with investors better. There is a lot of unanswered questions on how all this works but just like you did you took time to explain as much as you could and so thankful. Show's why you're doing great things and your company is moving up.
1 like Reply
Profile picture of Gail Meadus
Gail Meadus
almost 7 years ago
Congratulations John. Let’s go beat this horrible disease! Thank you for your perseverance.
0 Like Reply
Profile picture of Yanique Edouard
Yanique Edouard
almost 7 years ago
Congratulations on today's opening market.
1 like Reply
Profile picture of John Walsh
John Walsh
almost 7 years ago
Great work John, heroic effort! Great for shareholders and with the IPO your company now has a broader audience to grow and serve. Wish you best of success growing the company from here and for the future.
1 like Reply
Profile picture of Darran Webb
Darran Webb
almost 7 years ago
Congratulations on reaching this milestone. Look forward to a bright future
3 likes Reply
Profile picture of DHANJI HIRANI
DHANJI HIRANI
almost 7 years ago
Dhanji Hirani
What if i wanted to buy more shares, will that be at the discounted rate of $3.36?
1 like Reply
Profile picture of Aaron Hartley
Aaron Hartley
almost 7 years ago
Thank you!! John!!... unfortunate (speaking for myself only) that the feathers had to get rustled before getting information. Disappointed with Republic and Dawson for their inability or unwillingness to communicate over the past few weeks... This has ZERO to do with you or CNSP, as I am fully invested and vested in this company and your goals. I DO want to invest more, but hard to do so without clear communication for this entities on how to make it so. Either way, congratulations to you and all!!
3 likes Reply
Profile picture of Jeffery Hillebrandt
Jeffery Hillebrandt Congratulations to all ! Time to make some money !!!
Almost 7 years ago
1 like
·
Reply
·
Almost 7 years ago
Join the discussion
Icon
Verify your identity to join the discussion
To keep discussions authentic and prevent spam,
we ask users to verify their identity.
Verify your identity
Your information is kept secure and will only be used for identity verification.

Open for investment

Investors in CNS Pharma also invested in these companies. View more
Logo of Rentberry

Rentberry

Invest Pre-IPO in the AI Revolution Transforming $13...

Republic Funding Portal · Reg CF
Logo of Code Blue

Code Blue

AI that calls for help when you can’t

Republic Funding Portal · Reg CF
Logo of Mintworks

Mintworks

$30T opportunity by 2030. We turn any asset into dig...

Republic Funding Portal · Reg CF
Loading...
Back to CNS Pharma deal page
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Tokenized assets
Company
  • About
  • Insights
  • Events
  • Contact
  • Security
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BitGo Trust Company, a South Dakota-chartered trust company and registered money services business. BitGo Trust Company is not an FDIC member. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BitGo Trust Company and are not guaranteed by BitGo Trust Company. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC